Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.
- NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_assertion description "[Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.
- NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_assertion evidence source_evidence_literature NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.
- NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_assertion SIO_000772 23200175 NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.
- NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_assertion wasDerivedFrom befree-2016 NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.
- NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_assertion wasGeneratedBy ECO_0000203 NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.
- befree-2016 importedOn "2016-02-19" NP1032550.RACumemiU7lXM5ZLQOh4g0lEVuSzJV8g6nBAvsIxB3TIs130_provenance.